Malondong, Cristine Mae M.
HRN: 23-72-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2023
MUPIROCIN 2%, 15G (TUBE)
09/26/2023
10/02/2023
TOPICAL
1squirt
BID
Skin Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes